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ABSTRACT 
 
      The history of health insurance in the United States has perpetuated and enabled a 
health care industry that has been rewarded for increased spending rather than cost 
control.  With the original plan setting no spending limit on health care providers, fee-for-
service reimbursement provided greater incentive to spend than to contain costs.  
Attempts to control the soaring costs of health care services have given rise to managed 
care insurance plans that base reimbursement on health outcome data.  Given that the 
birth of managed care includes stringent reimbursement guidelines and ensuing 
controversy over services provided or not provided, this study sought to determine if 
differences in quality of care existed between two common types of health insurance, fee-
for-service (FFS) and health maintenance organization (HMO) insurance plans for the 
most costly chronic illness, congestive heart failure (CHF).  Utilizing primary and 
secondary data obtained from an ongoing CHF study at the University of Tennessee 
Medical Center in Knoxville, Tennessee, this study compared CHF health outcomes 
between FFS and HMO insurance plans. 
     With an N of 154 cases, results revealed 0.37 of a day shorter length of stay in HMO 
members with an average of 4.95 and 5.32 days for HMO & FFS members respectively.  
In addition, HMO members displayed higher readmission rates with 25.6% of HMO 
members and 22.6% of FFS members readmitted to the hospital within 30 days of 
discharge with a related diagnosis.  For the previously stated outcomes, no statistically 
significant difference was found between the insurance plans.  Other findings included all 
six cases of mortality found in FFS insurance plans, however an exposed odds ratio test 
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did not indicate a statistically significant difference in mortality rates due to sample size 
and distribution.  All six cases of mortality were found in patients ages 67 and up with an 
association between being age 67+ and enrolled in a FFS insurance plan. 
     Recommendations for future research include further study into length of stay and the 
possible effect on readmission rates for members of HMO insurance plans.  Investigation 
into documentation of teaching, follow-up scheduled at discharge, and the effect on 
readmission rates could provide data supporting the need for adequate teaching and 
follow up to decrease exacerbations and subsequent higher readmission rates. 
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CHAPTER I 
 
 
INTRODUCTION 
 
     This chapter covers the following topics: introductory background, the need for the 
study, the statement of the problem, research questions, basic assumptions, delimitations, 
limitations, and definitions.  This section provides a brief overview of the history of 
health insurance in the United States, including the emergence of managed care and the 
need for objective studies measuring the quality of care in managed care insurance plans.  
 
 
NEED FOR THE STUDY 
 
     The history of health insurance in the United States has perpetuated and enabled a 
health care industry that has been rewarded for increased spending rather than cost 
control.  With the original plan setting no spending limit on health care providers, fee-for-
service reimbursement provided greater incentive to spend than to contain costs.  
Attempts to control the soaring costs of health care services have given rise to managed 
care insurance plans that base reimbursement on health outcome data.  Given that the 
birth of managed care includes stringent reimbursement guidelines and ensuing 
controversy over services provided or not provided, studies are needed to compare the 
quality of care provided by managed care insurance plans to the traditional method of 
health insurance, Fee-For-Service (FFS) cost reimbursement.  In the sections below, the 
demise of the fee-for-service system and need for health care reform including managed 
care is discussed.  
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Evolution of Health Care Industry Reimbursement 
     Although the rate of increase has slowed in the past few years, the cost of health care 
services in the United States (U.S.) adjusted in real dollars has continued to exceed the 
national rate of inflation for several decades (Getzen, 2000).  Attempts to reform the 
current system have left legislators, committee members, and health care professionals 
exhausted and most unfortunately, back at the drawing table.  In 1965, the introduction of 
Medicare and Medicaid provided the healthcare industry with greater financial resources 
from federal and state government funds.  Unbeknownst to policy makers at the time, a 
fee-for-service sleeping giant was created that transformed the health care industry into a 
capitalistic, major money-making industry driven by dollars and cents.  Decades later, as 
our nation ails in financial distress from the burden of attempting to finance health care 
services for its citizens, we have awakened to the realization that perhaps the initial plan 
did not include considerable foresight.  In accordance with the old adage...if your outgo 
exceeds your income, then your upkeep will be your downfall...the United States 
government took drastic measures in the 1980s when they instituted Diagnosis-Related 
Groups (DRGs) to help control the escalating costs of the fee-for-service industry that 
had been created.   
     Given the undisputed point that the health care system needed to be reformed due to 
the United States Government spending far too great a portion of the Gross Domestic 
Product (GDP) on health care services through Medicare and Medicaid expenditures, the 
birth of managed care sought to manage costs and ease the burden of financing health 
care services for the U.S. government as well as commercial insurance providers.  The 
advent of Health Maintenance Organizations (HMOs) brought about decreased health 
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care expenditures by managing costs, but also raised a very important question: has the 
quality of care decreased along with costs?  Members enrolled in HMOs receive varying 
benefits compared to members enrolled in FFS (also known as traditional) insurance 
plans.  The question has been raised that HMO members receive a different, possibly 
decreased quality of care compared to members of traditional FFS insurance plans.  The 
foundation of managed care contract negotiations and the most reliable method to 
measure the quality of care is to evaluate patient (health) outcomes.  Patient outcome 
measurements investigate the outcome of disease interventions and compare the benefit 
or lack of benefit of various therapeutic measures.   
     Treatments prescribed by physicians are often predetermined by insurance coverage, 
with some treatments being the bridge between life and death.  Due to costs of expensive 
therapies insurance companies, and especially HMOs, provide certain therapies after 
greater scrutiny than has been provided for less expensive treatments.  The Agency for 
Healthcare Research and Quality (formerly the Agency for Health Care Policy and 
Research) has led the way to Patient Outcome Research Teams (PORTs) whose purpose 
is to fund multidisciplinary teams of investigators to identify effective care for a variety 
of common medical and surgical health problems (Hickey et al, 1996).  The goal is to 
disseminate the findings to the community to aid in the development of standards of care, 
the foundation of patient outcome measurement. 
     Tennessee has taken drastic measures to control escalating costs with the 
implementation of TennCare in January of 1994.  In an attempt to contain excessive 
Medicaid expenditures, the state sought to introduce managed care to the Tennessee 
health care industry.  With the growth of managed care in Tennessee, there is a need for 
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health outcome studies in the state of Tennessee comparing the quality of care between 
managed care plans and the previous traditional fee-for-service method of 
reimbursement. 
Effects of Congestive Heart Failure on the Health Care Industry 
     Whether on a local, regional, or national level congestive heart failure health 
outcomes are of concern to all health care providers given the seriousness and prevalence 
of this chronic, debilitating illness.  The prevalence of CHF in the United States is 
approximately 4.7 million cases with an overall 5-year mortality rate of 50% (Whellan et 
al, 1999).  The economic burden of the illness is monumental.  Xuan et al (2000) 
conducted a retrospective study reviewing data from medical and pharmacy claims for 
CHF patients to examine the economic burden and treatment patterns for the illness in a 
managed care population.  They report $20.2 billion spent on CHF in the United States in 
1998 alone and conclude that improved management of the condition is needed to reduce 
morbidity and associated treatment costs.  Hospitalization has been concluded as the 
greatest source of economic burden.  Given half of the patients discharged with a CHF 
diagnosis return to the hospital within 90 days, revealing the difficulty in managing the 
condition, the economic burden could be eased by instituting better case management of 
CHF patients (Xuan et al, 2000).  Mackowiak (1998) recommended using a model to 
determine concentration of costs for a CHF population.  By separating costs by the type 
of service or treatment utilized within a population, data specific to a population can be 
generated.  In addition, information on the impact of various treatment strategies can be 
ascertained. 
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     To validate the need for measurement of congestive heart failure health outcomes in 
East Tennessee, one only has to look at the prevalence and seriousness of the illness, as 
well the obvious deficiency in the literature.  The leading cause of death in the state of 
Tennessee in 1997 was diseases of the heart, 308/100,000, with East Tennessee's 
prevalence rate higher than the state average, 312/100,000 (NAPHSIS, 1997).  Given that 
the leading cause of death in the state of Tennessee was diseases of the heart and East 
Tennessee's prevalence is higher than the state average (NAPHSIS, 1997), more heart 
related studies leading to increased accountability of insurance plans to the quality of care 
they provide are needed.   
     Tennessee statewide health outcome studies were found comparing TennCare 
managed care plans by managed care organization as well as studies comparing managed 
care plans to fee-for-service insurance plans (discussed in detail in Chapter 2).  Studies 
comparing health outcomes by insurance plan specific for congestive heart failure in the 
state of Tennessee could not be found.  The need for health outcome studies comparing 
the quality of care for post-hospitalized congestive heart failure patients by insurance 
plan is evidenced by the deficiency of published studies in the literature review.  There 
were no documented studies specific to measuring post-hospitalized congestive heart 
failure health outcomes by insurance plan in East Tennessee.  Of the limited number of 
East Tennessee health outcome studies comparing outcomes by insurance plan, two were 
found that evaluated perinatal outcomes following the implementation of TennCare in 
1994.  Cooper et al (1999) compared perinatal outcomes among the managed care 
organizations providing care to TennCare enrollees.  The appropriately designed study 
utilizing retrospective cohort analysis revealed varying mortality rates among the 
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managed care plans, but did not compare the rates to Tennessee's prior fee-for-service 
method of reimbursement.  Utilizing the same design, Ray et al (1998) compared 
perinatal outcomes for TennCare enrollees to the previous Medicaid fee-for-service 
method of reimbursement.  Their study revealed no changes in perinatal outcomes 
following the implementation of TennCare.  In another appropriately designed 
retrospective study utilizing secondary survey data to calculate the effects of TennCare 
on utilization and outcomes, Sloan et al (2000) performed multivariate analysis to 
compare the care of patients hospitalized for acute myocardial infarction between 
TennCare and private insurance plans.  Their study found no significant difference in the 
outcomes for TennCare and private insurance enrollees.  
     Nationally, studies supporting the need for further CHF outcome comparisons by 
insurance plan include Philbin et al (1998) who investigated the influence of payer status 
on the process of care and resource utilization among patients hospitalized for CHF in the 
New York State hospital system.  Their retrospective study reported shorter length of stay 
and lower hospital charges for HMO patients, taking into account that fewer days 
hospitalized decreased total charges.  In addition, they found Medicaid patients had 
longest length of stay, greatest hospital charges, and highest CHF readmission rate.  
Zannad et al (1999) further support the need for CHF studies given the prevalence of the 
illness and deficiency of recent epidemiological studies taking into account modern 
medical advances used in the treatment and management of patients with advanced CHF.  
An appropriately designed retrospective study conducted in Oregon by Hanyu et al 
(1998) utilized hospital discharge data to compare outcomes of care by insurance plan for 
elderly CHF patients discharged from the hospital in 1995.  They reported no short-term 
 7
outcome differences among the varying insurance plans but suggested further attention be 
given to the increased use of emergency departments by managed care patients.    
 
STATEMENT OF THE PROBLEM 
     The problem addressed in this study determined differences in quality of care as 
evidenced by post-hospitalized congestive heart failure health outcomes between FFS and 
HMO insurance plans.   
 
RESEARCH QUESTIONS 
     In order to address the afore stated purpose of the study, the following research 
questions were developed: 
Research Question #1: How do comparable health outcomes differ for post-
hospitalized congestive heart failure patients enrolled in 
FFS and HMO insurance plans? 
Research Question #2: How do health outcome measurements for post-
hospitalized congestive heart failure patients enrolled in 
FFS and HMO insurance plans affect comparable 
morbidity rates? 
Research Question #3: How do health outcome measurements for post-
hospitalized congestive heart failure patients enrolled in 
FFS and HMO insurance plans affect comparable mortality 
rates? 
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ASSUMPTIONS 
     The following basic assumption regarding the investigation is as follows: 
1. The secondary data provided was originally obtained using a valid and reliable 
instrument and appropriate methodology. 
 
DELIMITATIONS 
     For the purpose of this study the following delimitation was made:   
1. This study was delimited to patients discharged from the University of 
Tennessee Medical Center, Knoxville, with a diagnosis of congestive heart 
failure enrolled in either a FFS or HMO insurance plan. 
 
LIMITATIONS 
     For the purpose of this study, the following limitation was made: 
1. Due to the population being limited to post-hospitalized congestive heart 
failure patients in an East Tennessee health system, the generalizability of the 
findings will be limited to the patient population and geographical area from 
which the sample was selected. 
 
DEFINITIONS 
     For the purpose of this study the following definitions were developed: 
Centers for Medicare and Medicaid Services (CMS): Formerly known as the 
Health Care Financing Administration (HCFA), the CMS is a federal agency within the 
U.S.  Department of Health and Human Services that is responsible for running the 
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Medicare and Medicaid programs.  In collaboration with the Health Resources and 
Services Administration, CMS is also responsible for the State Children's Health 
Insurance Program (SCHIP). 
Fee-for-service insurance plan: A health insurance plan that reimburses providers a 
prearranged amount for specified treatments when billed for those treatments with little 
or no limitations on treatment set by the insurance provider. 
Health Care Financing Administration: Now known as the Centers for Medicare and 
Medicaid Services (CMS).  See CMS for definition. 
Health maintenance organization insurance plan: A health insurance plan that 
provides and/or reimburses health care services based on predetermined outcome criteria 
and manages each enrollee's care based on that criterion.  The focus of care is on 
prevention of disease. 
Managed care: A method of financing and administration of health services based 
on supervision of health care with a focus on prevention of disease. 
Medicare: A health insurance benefit provided by the United States government to 
qualified elderly and disabled citizens.  The Medicare Part A benefit is managed by the 
Centers for Medicare and Medicaid Services and is funded by taxpayer dollars. 
Post-hospitalized congestive heart failure health outcomes: Congestive heart 
failure is a cardiovascular disease condition secondary to the heart's inability to 
sufficiently pump the blood throughout the body; characterized by weakness, 
breathlessness, and edema usually found in the lower extremities secondary to venous 
stasis.  The health outcomes measured for this study included the following: 
1.  Average length of stay (days) 
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2.  Mortality 
3.  Gender (male/female) 
4.  Payor (FFS/HMO) 
5.  Readmitted within 30 days of discharge with related condition 
6.  Attending physician (cardiology, medicine, family practice, other) 
7.  Treated with ACE inhibitor 
8.  Follow-up with a health care provider within 2 weeks scheduled at discharge 
9. Documentation of teaching (discharge instructions) 
A.  Diet 
B.  Weight 
C.  Medications 
D.  Activity level 
E. CHF teaching booklet 
Quality of care: Quality of care is the value and/or quality of medical care provided 
to patients by health care providers, hospitals, and other health related services, most 
often measured by health outcomes.  For the purpose of this study, the quality of care is 
measured by the post-hospitalization congestive heart failure health outcomes described 
above. 
 
SUMMARY  
     In conclusion, the need for further studies comparing health outcome measures 
between FFS and HMO insurance plans is needed to maintain adequate quality of care.  If 
left unquantified and unreported, quality of medical care will be determined fiscally by 
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pecuniary interested accountants and chief executive officers (CEOs) of large insurance 
companies rather than the health care providers.  The goal of this study is to provide 
health outcome results by insurance plan, thereby increasing accountability of those plans 
to its enrollees.   
 
ORGANIZATION OF THE STUDY 
The following sections will include the literature review, methodology, results of the 
study, and conclusions. 
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CHAPTER II 
 
REVIEW OF LITERATURE 
 
INTRODUCTION 
     The purpose of this chapter was to review research and literature findings related to 
measurement of health outcome variations based on insurance status, specifically those 
comparing FFS and HMO insurance plans, in addition to those studies utilizing 
secondary data to further analyze health outcomes.  The studies reviewed reported 
primarily on secondary health outcome data obtained from large databases, from 
secondary hospital data, or data obtained by managed care organizations for fee schedule 
and length of stay research.  Evidence based medicine (EBM) was incorporated into the 
literature review process to provide a framework for establishing validity.  A brief section 
below defines the role of EBM in this study with subsequent sections reporting the 
literature findings based on content, methodology, and content and methodology 
combined.  
Evidence Based Medicine and Review of Observational Studies 
     First developed in the 1980s at McMaster Medical School in Canada, the goal of 
evidence based medicine seeks to improve the quality of clinical decisions by furnishing 
health care providers with a framework to review and integrate published research into 
their assessment and treatment of patient conditions (Sullivan, 2000).  The term has since 
been broadened to evidence based health care (EBHC) given its increasing scope of 
practice.  Large databases and health care providers ill-equipped to review enormous 
volumes of information contributed to the need for EBM.  To fully apply the principles of 
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 EBM, evidence based practitioners must have an understanding of the patient's 
circumstances or predicament, to identify knowledge gaps and frame questions to fill 
those gaps, to conduct an efficient literature search, to critically appraise the research 
evidence, and to apply that evidence to patient care (Guyatt et al, 2000). 
     Randomized controlled studies provide the highest level of evidence, however the use 
of observational studies is commonly required when comparing outcomes among health 
care providers or institutions (Naylor & Guyatt, 1996).  EBM provides guidelines to 
determine validity when reviewing observational studies.  The authors address the 
importance of reporting on the quality and comprehensiveness of the secondary data 
source.  Of greatest importance is for patients to be similar in all ways except for the 
outcome being measured, with the application of multivariate analysis to adjust for 
differences (Naylor & Guyatt, 1996).  In determining whether or not the data has been 
adjusted for differences among patients, Naylor and Guyatt propose three core questions 
in Table 2.1. 
     In addition to the above questions, the authors determine factors that may affect 
outcomes by asking who, what, when, and where the service was provided.  These key 
questions were applied to the published research reviewed later in this chapter.  The 
sections below contain a review of the literature with application of EBM principles. 
 
RESEARCH AND LITERATURE RELATED IN CONTENT 
The purpose of this section was to review research and literature related in content.  The 
sections below discuss the methodology of health outcome measurement, cost issues 
associated with those measurements, congestive heart failure (CHF) health outcomes  
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       Table 2.1:  Evidenced Based Medicine:  
                     Three Core Questions 
 
1. Are the outcome measures accurate and 
comprehensive? 
 
 
2. Were there clearly identified, sensible  
comparison groups? 
 
 
3. Were the comparison groups similar with 
respect to important determinants of 
outcome, other than the one of interest? 
 
           Source: Naylor & Guyatt, 1996  
 
 
 
specifically, and the economic burden of CHF on the health care industry including 
methods to decrease costs.   
Methodology of Health Outcome Measurement 
     Health outcome research findings guide the health care industry in the ultimate goal of 
providing cost-effective, high quality of care.  Schlenker (1996) proposed five convincing 
reasons to analyze outcomes of care: (a) payers are demanding information about the 
results of care delivery; (b) outcomes are an integral part of accreditation; (c) consumers 
have a right to know about outcomes; (d) regulatory agencies demand information about 
outcomes; and (e) outcomes represent the basic reason for providing care.  Well-designed 
methodologies of outcome measurement evaluation are essential due to the magnitude of 
the decisions made based on outcome findings.  Dobrzykowski (1997) recommends that a 
comprehensive outcomes management system include patient-reported measures of 
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health status and satisfaction, clinical measures of function and efficiency, and population 
descriptive information including age, diagnoses, and comorbidity, in addition to 
providing careful consideration for data collection protocol, training procedures, data 
processing, and statistical analyses (Dobrzykowski, 1997).   
     A division of the Department of Health and Human Services, the Agency for Health 
Care Research and Quality (formerly known as the Agency for Health Care Policy and 
Research) is conducting numerous outcome measurement studies across the nation.  
According to the AHRQ, outcome research has become the key to developing better ways 
to monitor and improve the quality of care (AHRQ, 1999).  The AHRQ seeks to provide 
safe and effective outcome measurement data to develop guidelines for physicians to 
follow, regardless of usual practices.  The results of the agency's research are aiding in 
the development of "report cards" that purchasers and consumers can use to assess the 
quality of care in health plans.   
     Using an observational design, Jennings et al (1999) provided a valuable framework 
for classifying outcome indicators by reviewing outcomes literature published since 1974 
from medicine, nursing and health services outcome indicator research.  By keyword 
searching Medline, the Computerized Needs Oriented Quality Measurement Evaluation 
System (CONQUEST), and the Healthcare Cost and Utilization Project (HCUP), the 
authors compiled a list of indicators based on frequency of citation, differences in the 
spectrum of philosophical perspectives, and empirical work examining actual outcomes 
(Jennings et al, 1999).  The authors recognized that the study was not comprehensive due 
to the vast amount of published outcomes research since 1974 but did not state the actual 
method of selecting the articles reviewed for the study.  From their review they found a 
 16
pattern that focused on three categories of outcomes research: patient-focused, provider-
focused, and organization-focused.  Although not identified in the review, they propose a 
fourth category, population-focused outcomes, be added to the categories to provide 
greater comprehensiveness.  Table 2.2 further defines their findings and provides an 
excellent tool for classifying outcome indicators.  The authors conclude that the 
integration of numerous outcome indicators from a variety of categories contributes to a 
more balanced view of health care delivery as compared with focusing on a few common 
indicators or only one category (Jennings et al, 1999). 
Cost Issues Associated with Health Outcome Measurement 
     Cost issues associated with the results of health outcome measurements have produced 
scrutiny among the patients, health care providers, and health insurance companies 
regarding the objective to receive, provide, and reimburse cost-effective, high quality of 
care.  Health outcomes were found to be of great interest to managed care organizations 
with multiple studies funded by HMOs.  Managed care organizations (MCOs) use 
outcome measurements to determine resource allocation and payment for various 
illnesses.   
     Contracts between health care providers (HCPs) and HMOs are often based on 
outcome measures.  Given that HMOs focus on outcome measures to control their 
expenditures for treatments, it has been discovered in this literature review that a 
deficiency exists in research comparing health outcomes between FFS and HMO 
insurance plans.  Sullivan (1999) contends that although the need for more managed care 
plan (MCP) and FFS plan comparison studies is obvious, the number of reliable studies 
has been minimal.   
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Table 2.2:  Outcome Indicators According to Category 
         
Subsets Definition  Unit of Unit of  General  Sample  
   Measure Analysis Examples  Indicators  
         
      Category:  Patient-focused    
         
Diagnosis- Measures related to a Patient Patient or Quantitative indices CBC  
Focused disease state or physical  sub- (lab values, results of PO2  
 condition; measured at  elements tests of physiological Apgar scores 
 a discreet level providing  within a function), other  Vital signs  
 information about  patient biomarkers, clinical signs Dyspnea  
 changes in a patients   and symptoms Weight gain  
 condition.        
         
Holistically- Measures related to a Patient Patient Overall measures of Behavioral parameters 
Focused person's responses or   health status or health-   
 adaptation to an alteration   related quality of life; Comfort/discomfort 
 in health; measured at a   self-reports of knowledge   
 global level to provide   or satisfaction;  Functional status/physical 
 objective and subjective   performance on  function  
 information about domains   objective tests    
       Psychological function 
         
       Social function 
         
       Activities of daily living 
         
       Mobility  
         
       Disability 
 
 
       Health status/health-related 
quality of life 
        
       Patient knowledge 
         
       Patient satisfaction 
         
       Symptom management 
         
      Category:  Provider-focused    
         
Professional Measures of provider Patient Provider Complication rates; Appropriateness of  
Provider proficiency and use of   interventions such as treatment  
 services    appropriate use of   
     medications; provider Sentinel events 
     profiling    
       Technical proficiency 
         
Family Measure of demands on Caregiver Caregiver Measures of family or Caregiver burden/strain 
Caregiver family members and   caregiver burden   
 significant others      Caregiver interaction 
 providing patient care       
         
      Category:  Organization-focused    
         
 Measures aggregated Patient Organization Measures across    Access to care 
 across patients to  
provide evidence of 
  organization's rates of 
untoward events, e.g. 
  
 an organizations   deaths, falls,    Cost  
 effectiveness   readmissions   
       Length of stay 
         
       Morbidity  
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Table 2.2:  Outcome Indicators According to Category Continued 
      
      
      
      
      
      
                      
                 Mortality 
  
                  Other rate-based outcomes 
                   e.g., Caesarean sections, 
                   infections, falls, 
                   medication errors,    
                   unplanned return to surgery
Source:  Based on Jennings, B.M., Staggers, N. & Brosch, L. (1999).  A classification scheme for outcome indicators.  
Image: Journal of Nursing Scholarship, 31(4), 381-388.     
 
  
 
He reports that only 2 comprehensive reviews of the literature published in peer-reviewed 
journals have been performed since 1980, both by Miller and Luft (1994 and 1997).  
Miller and Luft examined studies reporting on the differences in quality of care, cost, and 
utilization rates between MCP and FFS plans and concluded that the quality of MCP care 
was roughly the same as FFS care (Sullivan, 1999).  Sullivan further reviewed their 
findings for quality of care by controlling for breadth of insurance coverage, stating the 
need to limit MCP and FFS plan comparisons to those studies in which coverage and 
benefits in each setting are comparable due to differences in care seeking behavior based 
on services covered.  He found MCP care to be equal or inferior to the care provided by 
FFS plans.  Miller and Luft responded to Sullivan's review of their findings and purport 
that by controlling for the above, the number of studies with results favorable to HMOs is 
substantially reduced and the overall number of studies eligible for reanalysis would be 
reduced to an insignificant amount.  They state that adopting Sullivan's logic would be a 
disservice to policy makers, consumers, and purchasers who need to better understand 
potential consequences of differences in bundles of plan characteristics.  In addition, they 
state that improved measurement and reporting of both FFS and HMO plan performance 
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would allow regulators to evaluate plans, and consumers and purchasers choose among 
plans, on the basis of their comparative performance results (Miller, 2000).   
     In 1997, Margo Zink wrote of the ethical implications related to changes in the health 
care industry brought about by managed care.  Many divisions of health care services 
have experienced increased financial burden due to reimbursement limitations set forth 
by managed care organizations.  Zink states that although ethical challenges are present, 
managed care organizations experience greater responsibility and accountability due to 
their focus on cost-effectiveness.  MCOs maintain or attempt to maintain integrity by 
basing reimbursement and approved procedures on health outcome measurements that 
were previously determined.  Douglas Olsen (1995) also wrote of the MCO ethical 
implications in Ethical Cautions in the Use of Outcomes for Resource Allocation in the 
Managed Care Environment of Mental Health.  In addition to Zirk, Olsen postulated 
ethical cautions for MCOs when basing reimbursement for mental health services on 
outcome measurements.  The author states there is difficulty in defining good outcomes 
and recommends review based on process measurements instead of loosely defined 
health outcomes.   
     Jones et al (1997) reported on the lack of nurse involvement in outcome measurement 
initiatives in Policy Issues Associated with Analyzing Outcomes of Care.  The authors 
state that an endeavor on the local, national, and international levels has been undertaken 
to provide adequate outcome measurement data and has neglected to include nurses as 
valid resources in the research and development of such data.  They go on to state that 
nurses must get involved in the process and include their expertise in the development of 
outcomes of care.   
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     In 1993, Alexis Wilson wrote of the need for patient outcomes in Bridging Cost and 
Quality through Patient Outcome Measurement.  According to the article, our health care 
financing and delivery system contains more incentives to spend than to not spend 
(Enthoven, 1991).  In addition, our country is determined to receive top-notch 
technological care, and if not received, litigation ensues.  Due to high expectations, costs 
soar.  She concludes by stating that effective outcome measurements need to be instituted 
at every level, and that they will become the tools used to evaluate and purchase health 
care based on quality.   
Congestive Heart Failure Outcome Measurement 
     Studies related to CHF health outcomes were also reviewed given the subject of this 
study.  A chronic debilitating illness, CHF afflicts an estimated 4.7 million Americans 
with a 5-year mortality rate of 50% (Whellan et al, 1999).  In a collaborative effort 
between the American College of Cardiology, American Heart Association, and the 
Agency for Health Care Policy and Research, a series of guidelines outlining 
interventions for CHF were developed.  Table 2.3 further defines those interventions.  
Whellan et al (1999) suggest the guidelines need to add more recent clinical advances 
such as initiation and titration of beta blockers, titration of ACE inhibitor to high target 
dose, addition of spironolactone in patients with NYHA class III or IV, and maintenance 
of digoxin concentration at lower end of therapeutic range (0.6 - 1.0ng/ml).  They 
conclude by recommending the best approach to CHF treatment include close follow up 
and a multidisciplinary team comprised of a primary care physician, a cardiologist 
specializing in heart failure, and other health care providers including nurses, 
pharmacists, physical therapists, dieticians, and social workers.   
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Table 2.3:  CHF Treatment Recommendations 
  
! Asymptomatic patients with ejection fractions <35-40% should be treated with an 
ACE inhibitor. 
           
! All patients with symptoms suggestive of heart failure should undergo an evaluation 
including measurement of left ventricular function unless other disease is clearly 
evident. 
           
! Presence or suspicion of heart failure and/or any of the following findings usually 
indicates a need for hospitalization: evidence of acute myocardial infarction, 
respiratory distress, pulmonary edema, severe complicating medical illness, 
anasarca, symptomatic hypotension, heart failure refractory to outpatient 
management. 
           
! Diuretics should be used for patients with heart failure and/or signs of significant 
volume overload. 
           
! After a diagnosis of heart failure is established, all patients should receive 
counseling on the disease, the prognosis, the symptoms to watch for, and the 
different therapies available. 
           
! All patients with heart failure should be given a trial of ACE inhibitors unless
specific contraindications exist. 
           
! Patients with ischemic cardiomyopathy should be advised of the possibility of 
revascularization unless they have a specific contraindication. 
 
Source: AHCPR/Whellan et al, 1999 
 
Smith & Konstam (1999) further support prevalence and cost by stating that CHF 
remains the most common Medicare discharge diagnosis with overall direct costs in 
excess of $10 billion in 1990, more than two thirds of the monies spent on hospital care. 
     Croft et al (1999) identified a national cohort of Medicare patients utilizing secondary 
data obtained from Medicare hospital claims records (1984-1986) and Medicare 
enrollment records (1986-1992) to observe 6-year heart failure survival in patients older 
than 67 years of age.  Probability of patient survival after their first hospitalization for 
heart failure was determined utilizing Cox proportional hazards regression for groups 
 22
defined by race, sex, age, Medicaid eligibility, and comorbid conditions.  Utilized when 
there are time-dependent censored observations, the Cox regression technique allows the 
independent variables in the regression equation to vary with time, the dependent variable 
being survival time of the patient (Dawson-Saunders & Trapp, 1994).  The authors 
recognize that the sample size of 170,239 patients 67 years or older admitted and 
discharged with a primary diagnosis of heart failure in 1986 (total CHF claims submitted 
in 1986 was 1.2 million) may negate the generalizability of their findings to the national 
population, in addition to the fact that the study participants included only 
noninstitutionalized subjects who were healthy enough to participate.  Their study 
revealed one third of the patients died within the first year and only 19% of black men, 
16% of white men, 25% of black women, and 23% of white women survived 6 years 
(Croft et al, 1999).  In addition, an increase in mortality was associated with Medicaid 
eligibility (white adults only) and diabetes.  Their study further supports the needs for 
prevention and proper disease management of this chronic debilitating illness. 
     In a well-designed single center prospective randomized trial study, Rich et al (1995) 
assessed the effects of multidisciplinary interventions on rate of readmission, quality of 
life, and the overall cost of medical care for high risk, hospitalized CHF patients 70 years 
or older.  Study participants were randomized with the use of a treatment and control 
group.  Results revealed 90 day survival rates without readmission to be 75 patients in the 
control group (53.6%) compared to 91 patients in the treatment group (64.1%) with no 
significant difference noted.  However, a significant difference was determined when 
analysis was limited to survivors of the initial hospitalization (54.3% in control group and 
66.9% in the treatment group, p=0.04).  The authors concluded that a multidisciplinary 
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treatment strategy could reduce hospital readmissions for elderly CHF patients (Rich et 
al, 1995). 
Economic Burden of CHF on the Health Care Industry 
     As discussed earlier in the chapter, the economic burden of CHF on the health care 
industry is overwhelming.  The section below provides further analysis of those studies 
examining the economic burden of CHF. 
      Xuan et al (2000) performed a retrospective review of medical and pharmacy claims 
to examine the costs and treatment patterns for CHF patients in a managed care 
population.  Patients with a diagnosis of CHF and claims eligibility of at least one year 
were selected from 6 independent-practice-association HMO enrollee lists for the 
calendar year 1994.  They examined charges incurred by CHF patients for the 6 months 
following the initial CHF medical claim and the treatment received by those patients.  
The study revealed 378 of the 2777 CHF patients (14%) were admitted to the hospital 
with a cost of almost $3 million.  In addition, 78% of the population received prescription 
drugs, an average cost of $942 per patient (Xuan et al, 2000).  ACE inhibitors were the 
most commonly prescribed drug.  Fifty-four percent of the total CHF treatment costs 
went to hospitalization, and prescription drugs accounted for 38% of costs.  The authors 
conclude that decreasing hospital admissions/readmissions could markedly reduce the 
economic burden of CHF on the managed care population and suggest further research to 
conclude whether or not increased use of prescription drugs could contribute to decreased 
hospitalization rates and overall costs (Xuan et al, 2000). 
     Rauh et al (2000) performed a non-randomized controlled trial to observe the effects 
of a multidisciplinary treatment approach on length of stay, admission and readmission 
 24
rates, and costs to both patient and provider.  Participants were selected based on 
presence of a CHF diagnosis with 407 patients in control group and 347 in treatment 
group.  Via telephone interviews during the 90 days following discharge, the treatment 
group received intensive patient and family education on diet, compliance, and symptom 
recognition, in addition to outpatient infusion of inotropic agents and aggressive 
pharmacologic treatment for patients with advanced CHF (Rauh et al, 2000).  The authors 
did not provide information on refusals, exclusion of patients, or whether patients were 
lost to follow up.  Their results revealed the mean length of stay for the treatment group 
was 1.6 days less than the control group (statistically significant at .05 risk level) with 
decreased costs associated with decreased length of stay.  The authors conclude that a 
multidisciplinary CHF program can improve patient care in the hospital setting while 
significantly reducing costs to both patients and institutions (Rauh et al, 2000). 
     In conclusion, the overwhelming majority of studies support the need for more efforts 
aimed at prevention and control of exacerbation of CHF to improve outcome 
measurements and decrease overall costs.  In addition, further studies revealing CHF 
health outcome variations between FFS and HMO insurance plans are needed to 
determine whether a particular plan provides greater or lesser care in the presence of 
controlled expenditures. 
 
RESEARCH AND LITERATURE RELATED IN METHODOLOGY 
      The purpose of this section was to review research and literature related in 
methodology.  The previous section explored the various elements of health outcome 
measurement and CHF treatment costs, whereas the methodology section explores the 
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value of secondary data in well-designed research both related and unrelated to health 
outcome measurement.   
     The methods applicable to collecting health outcome data include primary data 
obtained from surveys or instruments prepared by the researcher.  More easily procured, 
secondary data obtained from hospital, federal, or other administrative databases provides 
an excellent source of valid research data.  The assessment tool currently under study and 
being considered for dissertation use involves an instrument developed by a board of 
cardiologists and other cardiac practitioners at the University of Tennessee Medical 
Center, Knoxville (UTMCK) that measures various CHF outcomes on selected patients at 
time of discharge.  The instrument was developed, in part, due to a nationwide study that 
CMS is conducting utilizing a federal Quality Management Review form that 
participating hospitals complete upon discharge.  The form was created by CMS who is 
analyzing the data for specified quality of care indicators.  The UTMCK is participating 
in CMS's study on measuring health outcomes related to one of the six possible areas of 
participation, CHF.  UTMCK developed a comprehensive instrument that collected more 
extensive CHF data than the form provided by CMS.  CMS's form clearly delineates and 
measures the quality of care administered to the patient in the hospital and upon 
discharge, based on pre-defined criteria that has been deemed safe and effective treatment 
for CHF patients.  The form does not allow for patient satisfaction parameters in defining 
quality of care, rather bases the quality on medical treatment.  In addition to the quality of 
care provided the type of insurance is also documented, thus enabling the researcher to 
obtain health outcome data and compare it by insurance plan.  No studies using this form 
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have been found in the literature review.  Further explanation of the UTMCK instrument 
from which this study collected secondary data is discussed in chapter three. 
     Hanchak & Kelly (1997) described the benefits of secondary data analysis to evaluate 
health outcomes in Using Administrative Data to Evaluate the Quality of Care.  The 
advent and advancement of medical informatics has opened a technological frontier for 
data collection and evaluation.  The authors describe how U.S. Quality Algorithms, Inc. 
(USQA) uses administrative data to measure and improve the quality of medical care in 
the United States.  The Health Profile Database, which can be accessed to collect and 
measure quality of medical care, includes information regarding services provided by 
primary care physicians, specialists, and hospitals that are paid through capitation or fee-
for-service reimbursement models.  In addition, information regarding pharmacy usage, 
laboratory and test results, patient satisfaction, and health status information can be 
retrieved as well.  The Health Profile Database focuses on chronic medical conditions, 
utilizing ICD-9, CPT-4, pharmacy codes, laboratory test results, and patient demographic 
information to classify patients within the database.  The authors conclude by stating that 
costly treatments invoked by chronic diseases can be managed more effectively by 
defining the conditions that will benefit from further medical treatment.  The following 
studies utilize secondary data in their methodology. 
     In Correlates of Health Status among Black and White Elderly, Yu et al (1998) 
performed a study utilizing secondary data from the National Health Interview Survey 
(NHIS) to examine the health status of non-institutionalized elderly in the United States.  
The NHIS is a health interview survey distributed annually by the National Center for 
Health Statistics.  The current study collected information regarding health and other 
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characteristics of each household member.  The computer program SUDAAN was used 
to analyze the findings, which allows incorporation of the complex sampling design of 
the NHIS into the variance estimation and the odds ratios (Yu et al, 1998).  The 
respondents were grouped into young-old (65-79) and old (80 years and older) groups.   
The elderly were asked by the NHIS to respond to self assessed health status questions 
with possible responses including excellent, very good, good, fair or poor.  Black and 
white populations were analyzed separately with other racial groups excluded from the 
study.  Logistic regression was used to examine correlates of health status.  Excellent and 
very good responses were grouped together as excellent health and good health was 
deemed the reference category.  Comparisons were made between excellent vs. good 
health and poor vs. good health.  Results revealed 30% of elderly reported excellent or 
very good health and 14% reported poor health.  Of the young-old and old categories, 
Whites reported better health than Blacks in both categories.  Of the White young-old 
who reported excellent health, they tended to be single, never married, better educated, 
and/or with higher income, fewer activity limitations, fewer chronic illnesses, and fewer 
physician visits in the last 12 months than the White old or either Black groups.  Higher 
educational levels reflected higher health reporting.  Further analysis regarding self 
assessment of health status by ethic group is needed to explain whether or not variation in 
self reporting is due to actual or perceived illness or disability.   
     Utilizing both primary and secondary data obtained from a federal database, Carroll et 
al (1999) explored parental concern over teens contracting AIDS.  Utilizing the Health 
Belief Model and a family systems perspective as a framework, they first collected 
secondary data from the National Commission on Children: 1990 Survey of Parents and 
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Children, and then collected primary data from telephone interviews.  The purpose of the 
study was to determine what factors predicted an adolescent's worry about contracting 
AIDS and to what extent parents agreed with their children.  Participants for this study 
were selected based on those who responded yes to "worry about AIDS" in the national 
study, and were further sub-sampled utilizing a random sample from telephone numbers 
as well as supplemental random samples of African American and Hispanic children.  
The data was collected over the telephone with interviews lasting approximately 30 
minutes.  Children ages 14 to 17 years of age were asked, "How much do you worry that 
you will get AIDS someday" and parents were asked, "How much do you worry that 
he/she will get AIDS?"  Responses with missing data or "don't know" responses were 
excluded from the study.  Data analysis was performed using Pearson's chi-square to 
compare the teen's worry score with influencing factors.  Cramer's Vor Kendall's Tau was 
used to test the strength of the relationships (Carroll et al, 1999).  Results revealed 46% 
of the parent/teen pairs agreed in their responses about worry over contracting AIDS. 
      In summary of other studies utilizing nonfederal databases to collect secondary data, 
several studies were performed to measure the impact of managed care on health care 
utilization and patient outcomes following emergency department visits.  The method 
included collection of secondary data from the patient's medical record.  O'Neil et al 
(1994), found that HMO enrollees were less likely to be hospitalized, less likely to utilize 
emergency department services, and have fewer visits to a primary provider in the 4 
month follow-up period.  The researchers controlled for health status at baseline and 
found no differences at the end of the 4-month period.  Pearson (1994) reported on the 
findings of a study performed to measure the impact of membership in an HMO on 
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hospital admission rates for patients presenting to the emergency department with acute 
chest pain.  Analysis of insurance status along with patient outcome data was performed 
after grouping patients in low, medium, and high-risk cohorts.  The patient's medical 
record was used to collect the secondary data.  The researchers found that hospital 
admission rates were similar for all high-risk patients, regardless of payment source.  
Surprisingly, HMO admission rates for low and medium risk patients was higher than for 
commercial insurance or other payment source.  The findings are contrary to previous 
studies, which report decreased hospitalization in HMO enrollees. 
     Concluding the methodology review, it is apparent that federal databases and medical 
records are an excellent source of secondary data.  Select federal databases are accessible 
through the Internet at the Center for Disease Control and Prevention's web site  
(www.cdc.gov).  In addition to the above, the CDC publishes reports through the 
National Center for Health Statistics, providing even greater access to volumes of 
national data.  Given the accessibility of information available through federal databases, 
they provide an excellent source for studies concentrating on secondary data analysis. 
 
RESEARCH AND LITERATURE RELATED IN CONTENT AND 
METHODOLOGY 
     The purpose of this section was to review research and literature related in content and 
methodology.  This section reviews general studies utilizing secondary data to compare 
health outcomes by insurance type, including studies related specifically to CHF.  Studies 
utilizing secondary data to compare health outcomes by insurance type are reviewed 
below.   
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Studies Utilizing Secondary Data to Compare Health Outcomes by Insurance Type 
     Utilizing CMS cost reports, Cher & Lenert (1997) reported on the possibility of 
potentially ineffective care (PIC) provided to Medicare patients enrolled in HMOs and 
traditional fee-for-service health plans based on outcome data for patients in critical care 
units.  The method included analysis of secondary data obtained from a Medicare 
administrative database for the state of California.  The database used, The Medicare 
Provider Analysis and Review (MEDPAR), contained information on age, sex, race, total 
hospital charges, length of hospital stay, ICU care indicators, International Classification 
of Diseases (9th Revision), Clinical Modification diagnosis and procedure codes, length 
of time from hospital admission to death during approximately 1 year of follow-up, and 
CMS indicators for reimbursement method (HMO vs. other).  In addition to the 
MEDPAR database, CMS's cost report minimum data set for each hospital was included.  
The data includes indicators such as type of hospital (rural vs. non-rural, teaching vs. 
non-teaching), hospital and ICU size, total hospital operating costs and charges, number 
of full-time residency positions, bed availability, and bed use (Cher & Lenert, 1997).  In 
addition to the above, 1994 wages for the metropolitan statistical areas of California 
obtained from CMS's website was included in the data.  All patients who received critical 
care services in the state of California in the fiscal year 1994 were included in the study.  
The relationship between risk of a PIC outcome and HMO membership was determined 
after adjusting for severity of illness and differences in organizational features of the 
treating institution (Cher & Lenert, 1997).  They found that PIC was less common among 
HMO enrollees, however HMO enrollees were less likely to die in the hospital (possibly 
indicating a decreased hospitalization rate for HMO enrollees).  If HMO enrollee 
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hospitalization rates are lower, PIC results may be skewed due to lack of data on those 
enrollees who die outside of the hospital.  The authors concluded that HMO plans may 
avoid misuse of critical care resources near the end of life compared to FFS plans. 
     Other related studies included Riley et al (1999) who reported their findings in the 
Journal of the American Medical Association, Stage at Diagnosis and Treatment Patterns 
among Older Women with Breast Cancer: An HMO and Fee-For-Service Comparison.  
 Utilizing cancer registry data from the National Cancer Institute's Surveillance, 
Epidemiology, and End Results (SEER) program (data linked to Medicare enrollment 
records), the researchers investigated the treatment patterns for elderly women with 
breast cancer based on stage at diagnosis and type of insurance.  HMO and fee-for-
service (FFS) insurance plans were compared.  The SEER database includes information 
on month and year of diagnosis, cancer site, patient demographics, extent of disease at 
diagnosis, and therapy administered within 4 months of diagnosis (Riley et al, 1999).  
Women 65 or older who were entitled to Medicare part A and B benefits with breast 
cancer between 1988 and 1993 were included in the study.  Medicare enrollment records 
disclosed information regarding enrollment in either HMO or FFS setting.  Cases with 
bilateral disease, those with no mass found, those who switched from HMO to FFS or 
vice versa within 4 months of diagnosis, and cases not treated by either breast conserving 
surgery or total/modified radical mastectomy were excluded from the study.  Information 
regarding stage at diagnosis and treatment patterns was gleaned from the SEER database 
and then compared based on HMO or FFS enrollment.  Results revealed HMO enrollees 
were less likely to have breast cancer diagnosed at late stages than FFS patients.  In 
addition, women diagnosed with early stage breast cancer received similar rates of breast 
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cancer surgery regardless of payment source.  For those undergoing surgery, HMO 
enrollees were more likely to receive radiation therapy.  In conclusion, the authors state 
that the differences reported were often inconsistent and that HMO enrollees did not 
appear to have access problems (HMO agreeing to pay for the treatment) obtaining 
radiation therapy after breast cancer surgery than women in FFS settings. 
     Laurance Baker (1999) studied the variations in treatment levels for fee-for-service 
Medicare patients based on the prevalence of managed care in geographically defined 
areas.  In Association of Managed Care Market Share and Health Expenditures for Fee-
For-Service Medicare Patients, Baker used secondary data from a CMS database to 
compare expenditures for the care of Medicare fee-for-service beneficiaries in areas with 
and without a high HMO market share.  The method included comparing Medicare 
market share between predominantly HMO and FFS areas.  The main independent 
variable was the system-wide HMO market share in each market area (Baker, 1999).   
Due to the possible nonlinear relationship between HMO market share and expenditures 
(presence of a greater number of healthier members transferred to HMO plans with 
sicker, more costly patients left in FFS plans) the expenditures would rise per capita in 
FFS plans as the HMO enrollment increased, therefore inclusion of both system wide 
HMO market share and its square was performed.  The findings reported that in all areas 
defined, an increase in HMO market share reflected a decline in Medicare fee-for-service 
expenditures.  A direct association between high levels of managed care and decreased 
fee-for-service Medicare expenditures was determined.  The above study further supports 
the applicability of secondary data previously obtained by the Centers for Medicare and 
Medicaid Services to studies relevant to the data on hand.   
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     Himmelstein et al (1999) compared 14 quality of care measures for investor-owned 
and not-for-profit HMOs.  Using data obtained from the National Committee for Quality 
 Assurance's Quality Compass 1997, including the Health Plan Employer Data and 
Information Set (HEDIS) and HMO accreditation surveys, the researchers found that 
investor-owned plans scored lower on all 14 quality of care indicators that were assessed.  
After controlling for model type, geographic region, and the method each HMO used to 
collect data, the researchers determined investor-owned plans consistently scored lower 
in all areas reviewed.  The group concluded that based on their research findings, 
investor-owned HMOs deliver a lower quality of care than not-for profit HMOs. 
     Sidorov et al (1997) conducted a descriptive study to measure the success of a tobacco 
cessation program that compared quit rates among managed care enrollees and (not 
stated) non-managed care plans.  They found that non-HMO enrollees were less likely 
than HMO enrollees to achieve success.  They concluded by stating that tobacco 
cessation programs were more likely to benefit HMO enrollees, although the benefit to 
non-HMO members was significant.  The funding source for the study could not be 
determined. 
     Yelin, Criswell, & Feigenbaum (1996) reported health outcome differences among 
rheumatoid arthritis (RA) patients in prepaid group practice/HMO (PGP) and fee-for-
service (FFS) settings in Health Care Utilization and Outcomes Among Persons with 
Rheumatoid Arthritis in Fee-For-Service and Prepaid Group Practice Settings.  Utilizing 
annual telephone interviews for follow-up on an 11-year study, the authors concluded 
that despite literature findings prior to onset of the study, they found no difference in the 
quality or quantity of care provided to RA patients in either the PGP or FFS setting.  
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Given their findings, the authors conclude that method of reimbursement, specifically 
PGP or FFS, does not affect the quality of health care received. 
CHF Studies Comparing Outcomes by Insurance Type 
     A significant deficiency in literature existed at the time of this literature review that 
compared CHF health outcomes between FFS and HMO insurance plans.  The following 
studies utilized secondary data to compare CHF outcomes by insurance type. 
     Hanyu et al (1998) examined CHF outcomes by insurance type in Managed Care and 
Outcomes of Hospitalization among Elderly Patients with Congestive Heart Failure.  
With the objective of examining the effects of HMO enrollment on the outcomes of  
hospitalization, the authors conducted a retrospective cohort study that reviewed the 
Oregon hospital discharge data set for patients 65 years or older with a diagnosis of CHF 
in the year 1995.  CHF patients were divided into 6 insurance groups that included 
managed care, Medicare, Medicaid, commercial or private insurance, self-pay, and other 
(not defined).  Data reviewed from the hospital discharge data set included admission to 
hospital via emergency department, length of hospital stay, in-hospital mortality rate, and 
readmission rate.  The study found that managed care patients were more likely to be 
admitted to the hospital via the emergency department.  After adjusting for age, sex, and 
comorbidity, managed care length of stay was similar to that of commercial or private 
insurance patients, but experienced a shorter length of stay compared to Medicare, self-
pay, and other patients.  No comment was made on differences between managed care 
and Medicaid patients.  No difference in the in-hospital mortality rate was found between 
the insurance groups.  Readmission rates were higher in managed care patients than for 
commercial insurance or Medicare patients, but after adjusting for confounding variables 
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no significant differences were found.  The authors conclude that no association between 
managed care and poor short-term outcomes of hospitalization in CHF patients exist but 
state that further attention needs to be paid to the increased use of emergency departments 
by managed care patients (Hanyu et al, 1998). 
     Philbin & DiSalvo (1998) examined the influence of payer status on the process of 
care and resource utilization among patients hospitalized for CHF in Managed Care for 
Congestive Heart Failure: Influence of Payer Status on Process of Care, Resource 
Utilization, and Short-term Outcomes.  In a retrospective study utilizing secondary data 
obtained from the Statewide Planning and Research Cooperative System database, they 
reviewed information on patients discharged in 1995 from New York State hospitals.  
Patients were separated by insurance plans that included HMO, indemnity, Medicaid fee-
for-service, and Medicare fee-for-service.  Information collected included demographics, 
comorbid illness, process of care, length of stay, hospital charges, mortality rate, and 
CHF readmission rate.  They found that noninvasive procedures were used with similar 
frequency and invasive procedures were used greater in HMO and indemnity insurance 
patients. After adjusting for patient characteristics and hospital type and location, HMO 
patients had shorter length of stay and lower hospital charges, in part due to decreased 
length of stay (Philbin & DiSalvo, 1998).  The authors conclude that managed care plans 
provide similar access to clinical services with fewer charges but further prospective 
study of short-term outcomes is needed to determine if the difference is due to patient 
mix or quality of care.      
     In conclusion, lower costs are associated with managed care plans, however the 
studies agree that further research is needed to determine whether or not it is due to fewer 
 36
procedures and/or shorter hospital stays, or due to better case management by the 
managed care organization. 
     Concluding the content and methodology review, secondary data can be useful to 
subsequent studies.  Administrative data available through previous studies conducted by 
hospitals, CMS and other administrative sources can be gleaned for additional valuable 
information.  Unfortunately, the instrument to be used in the research at hand has no prior 
studies reported, although the information will be made available to researchers in the 
future.   
 
SUMMARY  
     In conclusion, the literature review revealed a deficiency of studies devoted to 
measuring health outcomes based on insurance type.  Given that managed care has 
continued to grow and is unlikely to decline in fiscal appeal, objective measurement of 
health outcomes for MCO enrollees, HMO in particular, is crucial for the development of 
safe, effective health plans that provide adequate health care.  Without accountability to 
documented objective outcome data, managed care organizations may provide their 
enrollees with decreased quality of care in their pursuit of financial gain.  As the literature 
review reveals, further studies comparing outcome data between managed care plans and 
fee-for-service plans are critical to the future of accountable health care service financing. 
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CHAPTER THREE 
 
METHODS AND PROCEDURES 
 
INTRODUCTION 
     The purpose of this chapter was to define the study population, the instrument to be 
used for data collection, and the procedures for treating the data.  The population 
included patients treated for and diagnosed with congestive heart failure at an East 
Tennessee hospital.  The method for data collection included retrieval of secondary data 
from a CHF monitor developed by the hospital to investigate variables specific to CHF 
health outcomes.  The sections below describe the population, instrument, and research 
design in further detail. 
 
STUDY POPULATION 
     The purpose of this section was to describe in detail the population to be studied as 
well as the geographical area from which the sample was selected.  The sample included 
patients discharged from the University of Tennessee Medical Center in Knoxville,  
Tennessee (UTMCK) with a diagnosis of congestive heart failure who were enrolled in 
either a fee-for-service or health maintenance organization health insurance plan.  The 
attending physician and/or cardiologist determined the diagnosis of congestive heart 
failure.  Eligible patients included those in which UTMCK's CHF monitor had been 
administered and was limited to enrollees of FFS or HMO insurance plans.  The 
following section describes pertinent statistical data regarding the population studied. 
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Population Statistics 
     The total population for East Tennessee in 1998 was 633,183, compared to  
366,846 in Knox County and 5,430,621 statewide**.  The 1998 population by gender 
included  329,205 females and 303,978 males in East Tennessee, 192,922 females and 
173,924 males in Knox County, and 2,830,813 females and 2,599,808 males statewide.  
Of significance to the need for this study, the leading cause of death in 1997 for the state 
of Tennessee was cardiovascular diseases.  The 1997 death rate per 100,000 for diseases 
of the heart in Knox County Tennessee was 265.8, compared to 312.1 in East Tennessee 
and 308.1 statewide (no Tennessee data specific to congestive heart failure was 
available).  The 1997 diseases of the heart death rates per 100,000 by gender included 
298.1 females and 327.3 males in East Tennessee, 259.2 females and 273.2 males in 
Knox County, and 297.6 females and 319.5 males statewide.  The study population 
included a convenience sample of both males and females consisting of all patients 
admitted to UTMCK with a primary diagnosis of CHF and discharged with the same 
primary diagnosis during the study period.  Given the significant prevalence of the 
disease in both genders (although higher in males), the study included both genders but 
did not separate by race or ethnicity.   
The East Tennessee environment is rich in vegetation and forestry, but unfortunately the 
culture of the area patronizes a lifestyle consistent with increased cardiovascular disease 
risk.  Risk factors such as high fat foods including meats and vegetables fried in oil, 
                                                
* Nonmetropolitan East Tennessee region includes Anderson, Blount, Campbell, Claiborne, Cocke, 
Grainger, Hamblen, Jefferson, Loudon, Monroe, Morgan, Roane, Scott, Sevier, and Union counties. 
 
* All statistics obtained from the Tennessee Department of Health and Health Information Tennessee web 
site 
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smoking, and obesity are all prevalent in East Tennessee.  More studies addressing the 
outcomes of diseases brought about by poor lifestyle practices are needed.  The 
quantification of congestive heart failure health outcomes by insurance plan can 
contribute to increased community awareness, as well as providing accountability to 
insurance companies for treatments provided or withheld. 
 
INSTRUMENTATION 
     The purpose of this section was to describe in detail the instrument and methods used 
to obtain the data.  The following sections detail the instrument selected and the method 
of administration, including the follow-up procedure for insufficient sample size and data 
tabulation. 
Selection of the Instrument 
     For the purpose of this study, secondary data were collected from UTMCK's CHF 
monitor (see Appendix A).  After collaborating with CMS to collect CHF outcome data 
for a national study, UTMCK developed their own CHF instrument utilizing a panel of 
physicians that included cardiologists to modify and expand the original CMS instrument 
in order to collect more comprehensive CHF data not available on the CMS instrument.   
Validity and reliability of the instrument remains an assumption given that it was not 
tested for validity and reliability after modification. 
     The health outcome measurements for this study obtained from UTMCK's CHF 
monitor included the following: 
1.  Length of stay (days) 
     2.  Mortality 
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     3.  Gender (male/female) 
     4.  Payor (FFS/HMO) 
     5.  Readmitted within 30 days of discharge with related condition 
    6.  Attending physician (cardiology, medicine, family practice, other) 
     7.  Treated with ACE inhibitor 
     8.  Follow-up with a health care provider within 2 weeks scheduled at 
             discharge 
     9.  Documentation of instruction (discharge instructions) 
      A.   Diet 
      B.  Weight 
      C.  Medications 
      D.  Activity level 
      E.  CHF teaching booklet 
In addition to the above health outcome measurements, the type of insurance was 
recorded with selection limited to patients enrolled in either a fee-for-service or health 
maintenance organization insurance plan. 
 
METHOD OF ADMINISTRATION 
     Utilizing registered nurses in the Department of Medical Management, UTMCK 
originally collected outcome data via chart reviews.  Secondary data analysis of the CHF 
monitor for this study was performed by registered nurses with sample selection based on 
a diagnosis of CHF and enrollment in a FFS or HMO insurance plan.  The health 
outcome information collected was described in the previous section.    
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FOLLOW-UP PROCEDURE FOR INSUFFICIENT SAMPLE SIZE 
     In the event a sample size less than 150 is obtained from the available secondary data 
sample, the sample size can be increased by performing further chart reviews to provide 
more primary data.  The addition of primary data from the same instrument is feasible 
given that access to the University of Tennessee Medical Center's CHF patient population 
has already been approved.  Approval from the hospital Institutional Review Board 
would be obtained prior to accessing the medical record for more primary data. 
 
DATA TABULATION 
     Once the CHF outcome measurements were collected through secondary data analysis 
of the CHF monitor, they were compared by insurance plan.  All of the afore described 
indicators will be compared by insurance plan.  The section below defines how the data 
was analyzed. 
 
PROCEDURES FOR TREATING THE DATA 
     The purpose of this section was to describe the procedures for treating the data.  Once 
the data was obtained, the following statistical methods were applied to the data. 
     An exposed odds ratio was utilized to determine an estimate of relative risk, or the 
relationship between two characteristics (insurance plan and outcome).  The test 
determines the odds in favor of being exposed for diseased subjects divided by the odds 
in favor of being exposed for non-diseased subjects.  The test can also be used to measure 
association between exposure and disease.  For this study, multiple 2 x 2 contingency 
tables were developed where insurance type equaled exposure (e.g. FFS insurance, yes or 
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no) and outcome equaled each selected variable from the CHF instrument (e.g. treated 
with ACE inhibitor, yes or no).  Utilizing SPSS for statistical analysis, tables were 
created from collected data that calculated odds ratios (risk estimates) between selected 
variables.  Table 3.1 provides an example of one contingency table that presented the 
outcome as "treated with ACE inhibitor" and the exposure as "fee for service insurance." 
     The two possible exposures were 1) enrollment in a FFS insurance plan and 2) 
enrollment in an HMO insurance plan.  The following odds ratio outcomes were collected 
for FFS insurance type and then again for HMO insurance type: 
1. Mortality 
2. Readmitted within 30 days of discharge with related condition 
3. Treated with ACE inhibitor 
4. Follow-up with a health care provider within 2 weeks scheduled at discharge 
5. Documentation of teaching (discharge instructions) 
A. Diet 
B. Weight 
C. Medications 
D. Activity level 
E. CHF teaching booklet 
For each of the above outcomes, a 2 x 2 contingency table was created for members of 
FFS insurance plans and again for members of HMO insurance plans.  SPSS software 
provided statistical analysis and calculated the risk estimates at a 95% confidence interval 
for each of the above exposure and outcome combinations. 
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Table 3.1: Odds Ratio Example 
                 Outcome 
       Treated with ACE Inhibitor   
   Yes No Total  
 Fee-for-   Yes  x x x  
Exposure Service         
 Insurance    No  x x x  
       
    Total  x x x  
 
 
 
     In addition to these outcome measures, an independent sample t-test was used to test 
the null hypothesis that average length of stay of HMO members is equal to the average 
length of stay of FFS members.  To determine whether or not the class of attending 
physician is dependent upon the type of insurance, a Pearson's chi-square test of 
independence was used.  Table 3.2 summarizes each outcome measure collected and the 
statistical test used to analyze the data.  
 
SUMMARY 
     In conclusion, instrument selection was followed by the development of a 
methodology most appropriate for the type of data to be collected in this case-control 
study.  Composed of multiple risk estimates, the exposed odds ratio is an appropriate test 
to determine whether a significant difference in the selected variables exists.  In addition 
to the exposed odds ratio, tests such as the independent sample t-test and Pearson's chi-
square test of independence can efficiently analyze data when testing the null hypothesis. 
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Table 3.2: Data Analysis Summary 
   Outcome Measure  Statistical Test  
         
   Average length of stay (days)  
    
    
Independent sample t-test to test the 
null hypothesis that average length  
of stay of FFS members is equal to  
the average length of stay of HMO 
members. 
         
   Mortality (yes or no)       Exposed 
odds ratio 
   
         
   Gender (male or female)  Categorical 
definition 
   
         
   Payor (FFS or HMO)  Categorical 
definition 
   
         
Exposed 
odds ratio 
      Readmitted w/in 30 days of discharge 
   with related condition (yes or no) 
     
         
Pearson's chi-square test of 
independence 
     
   Attending physician (cardiology,  
   medicine, family practice, or other) 
     
   Treated with ACE inhibitor (yes or no) Exposed 
odds ratio 
   
         
Exposed 
odds ratio 
      Follow-up with health care provider 
   scheduled at discharge (yes or no) 
     
         
   Documentation of discharge teaching  
   (yes or no) 
Exposed 
odds ratio 
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The following chapter provides the detailed results of data collection utilizing the above 
methodology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 46
CHAPTER IV 
 
ANALYSIS AND INTERPRETATION OF DATA 
 
INTRODUCTION 
     The purpose of this chapter was to present analysis of the data.  The chapter was 
divided into the following sections: 1) subject data, 2) results of the study, 3) analysis of 
the research questions 4) interpretation of the data and 5) summary.  
 
SUBJECT DATA 
     The sample included 154 subjects discharged from the University of Tennessee 
Medical Center, Knoxville (UTMCK) with a primary diagnosis of CHF between the 
years 1996 to 2000.  A stratified random sample of subjects was selected based on a list 
of all attending physicians at UTMCK caring for patients discharged with a primary 
diagnosis of CHF during the years specified above.  According to type of insurance, only 
those patients with FFS or HMO insurance plans were selected.  The age range was 19 to 
98, consisting of 82 females and 72 males.  The data revealed a disparity in age groups 
between insurance plans, with FFS plans comprising a larger percentage of subjects ages 
67 and up.  Table 4.1 summarizes the distribution by age and insurance plan with 
comprehensive data on age distribution by insurance plan presented in Appendix B. 
 
RESULTS OF THE STUDY      
     The following section describes in detail the results of the statistical tests defined in  
the Data Analysis Summary displayed in Table 3.2.  An alpha of .05 was selected for  
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level of significance criterion. 
     To test the null hypothesis that average length of stay (LOS) of FFS members is equal 
to the average LOS of HMO members an independent sample t-test was performed.  The 
mean LOS was 5.32 and 4.95 days for FFS and HMO members respectively.  After 
confirming homogeneity of variances, the t-test revealed no significant difference in LOS 
between the insurance plans.  Calculation of design power revealed a power of 7% with a 
difference of 2.5 days needed to obtain a power of 80%.  Table 4.2 reveals less than half 
of a day difference in length of stay between the insurance plans.  Table 4.3 displays the 
results of the t-test. 
     To determine relative risk of mortality by insurance plan, an exposed odds ratio test 
was performed.  Out of the 154 subjects, all 6 cases of mortality were found in FFS 
insurance plans, ages 67 and up.  Although all 6 cases of mortality were found in FFS 
insurance plans, the statistical test revealed no increased risk of mortality by insurance 
plan.  The results of the odds ratio are displayed in Table 4.4 with the distribution of 
mortality cases by insurance plan presented in Table 4.5.   
 
Table 4.1:  Age Distribution by Insurance Plan
22 36 58
37.9% 62.1% 100.0%
93 3 96
96.9% 3.1% 100.0%
115 39 154
74.7% 25.3% 100.0%
Count
% within Age Category
Count
% within Age Category
Count
% within Age Category
66 or less
67+
Age Category
Total
FFS HMO
Payor
Total
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Table 4.2: Mean Length of Stay by Insurance Plan
115 5.32 4.173 .389
39 4.95 6.304 1.009
Payor
FFS
HMO
LOS
N Mean Std. Deviation Std. Error Mean
 
 
 
Table 4.3: Independent Samples T-Test 
 LOS 
 Equal variances 
assumed
Equal variances not 
assumed
Levenes Test for 
Equality of Variance 
F 1.341
 Sig. .249
T-Test for Equality of 
Means 
t .420 .345
 df 152 49.768
 Sig. (2-tailed) .675 .732
 Mean 
difference
.37 .37
 Std. Error 
Difference
.889 1.082
 
95% Confidence 
Interval of the 
Difference 
Lower
Upper
-1.382 
2.129  
-1.800 
2.546
 
 
 
Table 4.4: Risk Estimate of Mortality by Insurance Plan 
  
Value   
             95% Confidence Interval              
             Upper                   Lower              
 
For cohort Mortality = No                 .948 
 N of Valid Cases                               154 
    
                .908                      .989          
 
 49
Table 4.5:  Mortality Distribution by Age and Insurance Plan
22 36 58
37.9% 62.1% 100.0%
22 36 58
37.9% 62.1% 100.0%
6 6
100.0% 100.0%
87 3 90
96.7% 3.3% 100.0%
93 3 96
96.9% 3.1% 100.0%
Count
% within Mortality
Count
% within Mortality
Count
% within Mortality
Count
% within Mortality
Count
% within Mortality
NoMortality
Total
Yes
No
Mortality
Total
Age Category
66 or less
67+
FFS HMO
Payor
Total
 
 
 
 
To control for age, Table 4.6 further defines relative risk of mortality by displaying 
results by age groups 66 or less and 67+. 
     To determine risk of hospital readmission within 30 days of discharge with a related 
diagnosis by insurance plan, an exposed odds ratio test was performed.  The data revealed 
22.6% of FFS cases and 25.6% of HMO cases were readmitted to the hospital within 30 
days of discharge with a related diagnosis.  The distribution of readmission cases by 
insurance plan is displayed in Table 4.7.  A risk estimate determined no increased risk of 
readmission between insurance plans as displayed in Table 4.8.   
     A Pearson's chi-square test of independence was performed to determine if the type of 
attending physician was dependent upon insurance plan.  The data revealed 43.5% of 
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Table 4.6:  Risk Estimate of Mortality by Age and Insurance Plan
.
a
1.034 .996 1.075
96
Odds Ratio for
Mortality (No / .)
For cohort Payor = FFS
N of Valid Cases
Age Category
66 or less
67+
Value Lower Upper
95% Confidence Interval
No statistics are computed because Mortality is a constant.a. 
 
 
 
 
Table 4.7: Distribution of Readmission Cases by Insurance Plan 
 Readmitted within 30 days 
with CHF related diagnosis? 
 
 Yes No Total 
    
Payor           FFS 26 89 115 
                  HMO 10 29 39 
 
                  Total 
 
36 
 
118 
 
154 
 
 
 
 
 
Table 4.8: Risk Estimate of Readmission Cases by Insurance Plan 
  95% Confidence Interval 
 Value Lower Upper 
Odds Ratio for Payor 
(FFS/HMO) 
 
.847 
 
.365 
 
1.965 
For cohort readmitted 
within 30 days with CHF 
related diagnosis? = Yes 
 
.882 
 
.468 
 
1.660 
For cohort readmitted 
within 30 days with CHF 
related diagnosis? = No 
 
1.041 
 
.844 
 
1.283 
N of Valid Cases 154    
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FFS cases and 46.2% of HMO cases received primary attending services from a 
cardiologist.  The distribution of subjects by attending physician (cardiology, family 
practice, medicine, or other) and insurance plan is displayed in Table 4.9.  Results of the 
Pearsons chi-square test of independence revealed no significant association between 
attending physician and insurance plan.  Table 4.10 further defines the results. 
     To determine risk of being treated with an ACE inhibitor by insurance plan, an 
exposed odds ratio was performed.  The data revealed 64.3% of FFS cases and 71.8% of 
HMO cases were prescribed an ACE inhibitor.  The distribution of subjects prescribed an 
ACE inhibitor by insurance plan is displayed in Table 4.11.  Results of the odds ratio 
revealed no increased risk of being prescribed an ACE inhibitor between the insurance 
plans.  Table 4.12 below displays the results of the test. 
     To determine if follow-up with health care provider scheduled at discharge was 
affected by insurance plan, an exposed odds ratio test was performed.  The data revealed 
87% of FFS cases and 92.3% of HMO cases were scheduled for follow-up within 2 
weeks following discharge from the hospital.  The distribution is displayed in Table 4.13. 
 
 
 
 
 
    Table 4.9: Distribution of Subjects by Attending Physician and Insurance Plan 
  Attending Physician   
 Cardiology Family Practice Medicine Other Total 
Payor         FFS 
                HMO 
50 
18 
16 
5 
43 
13 
6 
3 
115 
39 
           
                Total 
 
68 
 
21 
 
56 
 
9 
 
154 
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Table 4.10: Pearsons Chi-Square Test of Independence to Determine  
Association Between Attending Physician and Insurance Plan 
  Asymp. Sig. 
 Value df (2-sided) 
    
Pearson Chi-Square  .510* 3 .917 
 
Likelihood Ratio 
 
.494 
 
3 
 
.920 
 
Linear-by-Linear 
Association                 
 
.009 
 
1 
 
.925 
N of Valid Cases      154   
 
 
                  *.  1 cell (12.5%) has an expected count less than 5.  The minimum expected count is  
                       2.28. 
 
 
 
 
 
 
Table 4.11: Risk of ACE Inhibitor Prescribed by Insurance Plan 
 ACE Inhibitor Prescribed  
 Yes No Total 
    
Payor           FFS 74 41 115 
                  HMO 28 11  39 
    
          Total 102 52 154 
      
 
 
 
 
 
Table 4.12: Risk Estimate of ACE Inhibitor Prescribed by Insurance Plan 
  95% Confidence Interval 
 Value Lower Upper 
Odds Ratio for Payor 
(FFS/HMO) 
 
.709 
 
.320 
 
1.570 
For cohort ACE Inhibitor 
Prescribed? = Yes 
 
.896 
 
.706 
 
1.138 
For cohort ACE Inhibitor 
Prescribed? = No 
 
1.264 
 
.724 
 
2.208 
N of Valid Cases 154    
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Results of the odds ratio test revealed no increased risk of follow-up being scheduled 
within 2 weeks at time of discharge between the insurance plans.  Table 4.14 displays the 
results of the risk estimate. 
     To determine differences in risk of documentation of discharge teaching by insurance 
plan, an exposed odds ratio test was performed.  Out of an N of 120, the data revealed 
44% of FFS cases and 51.7% of HMO cases had complete documentation of discharge 
teaching.  Table 4.15 displays the distribution of cases.  Results of the odds ratio test 
revealed no increased risk of documentation of discharge teaching by insurance plan.  
Table 4.16 displays the results of the test. 
 
Table 4.13: Follow-up Scheduled within Two Weeks by Insurance Plan 
Follow-up scheduled within 2 weeks  
following discharge? 
 Yes No Total 
    
Payor           FFS 100 15 115 
                  HMO 36 3  39 
 
                  Total 
 
136 
 
18 
 
154 
 
 
Table 4.14: Risk Estimate of Follow-up Scheduled at Discharge by Insurance Plan 
            95% Confidence Interval 
 Value   Lower Upper 
Odds Ratio for Payor 
(FFS/HMO) 
 
.556 
 
.152 
 
2.032 
For cohort follow-up 
scheduled within two weeks 
following discharge? = Yes 
 
.942 
 
.840 
 
1.057 
For cohort follow-up 
scheduled within two weeks 
following discharge? = No 
 
1.696 
 
.518 
 
5.547 
N of Valid Cases 154    
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Table 4.15: Documentation of Discharge Teaching by Insurance Plan 
 Documentation of discharge 
teaching? 
 
 Yes No Total 
    
Payor           FFS 40 51 91 
                  HMO 15 14 29 
 
                  Total 
 
55 
 
65 
 
120 
             
 
 
Table 4.16: Risk Estimate of Discharge Teaching by Insurance Plan 
  95% Confidence Interval 
 Value Lower Upper 
Odds Ratio for Payor 
(FFS/HMO) 
 
.732 
 
.317 
 
1.692 
For cohort documentation 
of discharge teaching? = 
Yes 
 
.850 
 
.558 
 
1.295 
For cohort documentation 
of discharge teaching? = 
No 
 
1.161 
 
.764 
 
1.764 
N of Valid Cases 120    
 
 
 
ANALYSIS OF THE RESEARCH QUESTIONS 
The research questions proposed in Chapter 1 are addressed in the following section.   
Research Question #1: How do comparable health outcomes differ for post-
hospitalized congestive heart failure patients enrolled in 
FFS or HMO insurance plans? 
Analysis: The health outcomes assessed to address research question 
1 included attending physician, follow-up with health care 
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provider scheduled at discharge, and documentation of 
discharge teaching.  According to the results of this study, 
there are no statistically significant differences in health 
outcomes between FFS and HMO insurance plans.   
Research Question #2: How do health outcome measurements for post-
hospitalized congestive heart failure patients enrolled in  
and FFS insurance plans affect comparable morbidity 
rates? 
Analysis: The health outcomes assessed to address research question 
2 included length of stay, readmission within 30 days of 
discharge with a related diagnosis, and treated with an ACE 
inhibitor.  According to the results of this study, no 
statistically significant association between morbidity rates 
and insurance plan was found.  Although shorter LOS and 
higher readmission rates for HMO members were revealed, 
no statistically significant differences were discovered. 
Research Question #3: How do health outcome measurements for post-
hospitalized congestive heart failure patients enrolled in 
FFS and HMO insurance plans affect comparable mortality 
rates? 
Analysis: The health outcome assessed to address research question 3 
included mortality rates for each insurance plan.  Results 
revealed all six cases of mortality in FFS insurance plans; 
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however an exposed odds ratio test did not indicate a 
statistically significant difference in mortality rates due to 
sample size and distribution.  All six cases of mortality 
were found in patients ages 67 and up.  It was also 
discovered that an association between being age 67+ and 
enrolled in a FFS insurance plan was present.   
 
INTERPRETATION OF THE DATA 
     The data presented in this study revealed no statistically significant difference in 
congestive heart failure health outcomes between FFS and HMO insurance plans.  Given 
that managed care reimbursement guidelines are more stringent than FFS plans, the 
implications of the findings of this study indicate that managed care plans (specifically 
HMO plans) do not compromise quality of care in the administration and reimbursement 
of health care services for congestive heart failure patients.  The sections below discuss 
the implications of the findings of this study as they relate to health care providers, 
patients, and the health care industry as a whole. 
Implications of Findings for Health Care Providers 
     Based on the findings of this study, the quality of care for congestive heart failure 
patients does not vary between FFS and HMO insurance plans.  Given the above 
findings, the method of reimbursement (specifically FFS or HMO insurance plans) does 
not affect the quality of care administered by health care providers.  No statistically 
significant differences were found by attending physician, therefore physician specialty 
(cardiology, family practice, medicine, or other) does not affect the quality of care 
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provided for congestive heart failure patients enrolled in FFS or HMO insurance plans.  
Based on the above, physicians caring for congestive heart failure patients should not find 
significant differences in the health outcomes for those patients enrolled in FFS and 
HMO insurance plans. 
Implications of Findings for Patients 
     With approximately 4.7 million cases and an overall 5-year mortality rate of 50% for 
congestive heart failure patients (Whellan et al, 1999), the seriousness of this illness is 
undisputed.  Based on the findings of this study, patients with congestive heart failure 
enrolled in FFS and HMO insurance plans should not be affected by payor source in the 
quality of care they receive from their insurance plan and more specifically, their health 
care providers.   
     The study revealed a higher percentage of patients ages 67+ enrolled in FFS insurance 
plans compared to patients enrolled in HMO insurance plans.  The findings are likely 
related to the high number of Medicare patients that comprised the FFS group and the 
fact that CHF is more prevalent in the elderly population.  In addition, Medicare HMOs 
are not as prevalent in the East Tennessee area as compared to other areas of the United 
States, thereby contributing to decreased numbers of elderly HMO members available for 
this study. 
Implications of Findings for the Health Care Industry 
     Given the undisputed fact that heart disease is the number one cause of death in 
Americans today with congestive heart failure comprising one of the most costly 
diagnosis groups, the payors, patients, and health care providers should not see a 
difference in the quality of care provided between congestive heart failure patients 
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enrolled in FFS or HMO insurance plans.  Nationwide, half of the patients discharged 
with a CHF diagnosis return to the hospital within 90 days, revealing the difficulty in 
managing the condition (Xuan et al, 2000).  The data in this study revealed 22.6% of FFS 
cases and 25.6% of HMO cases were readmitted to the hospital within 30 days of 
discharge with a related diagnosis, and no statistically significant difference in 
readmission rates found between the insurance plans.  As indicated in previous studies, 
better case management of CHF patients could possibly contribute to decreased 
readmission rates and subsequent costs associated with treatments and hospitalizations.  
This study revealed HMO patients had a shorter length of stay and 3% higher 
readmission rate, possibly indicating that the managed care plans in this study did not 
positively affect readmission rates as compared to FFS patients who received no case 
management through their insurance plan.   
 
SUMMARY 
     In summary, no statistically significant difference in health outcome measurements 
between FFS and HMO insurance plans was revealed, however differences do exist.  The 
following chapter will discuss a summary of the findings, conclusions, and 
recommendations. 
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CHAPTER V 
 
SUMMARY, FINDINGS, CONCLUSIONS, AND RECOMMENDATIONS 
 
INTRODUCTION 
     This chapter is divided into the following 4 sections: summary of the study, findings 
of the study, conclusions, and recommendations. 
 
SUMMARY 
     The problem addressed in this study determined differences in quality of care as 
evidenced by post-hospitalized congestive heart failure health outcomes between FFS and 
HMO insurance plans for patients discharged from the University of Tennessee Medical 
Center, Knoxville.  To accomplish this, the following three research questions were 
developed:   
1.  How do comparable health outcomes differ for post-hospitalized congestive 
     heart failure patients enrolled in FFS and HMO insurance plans? 
2. How do health outcome measurements for post-hospitalized congestive heart 
failure patients enrolled in FFS and HMO insurance plans affect comparable 
morbidity rates? 
3. How do health outcome measurements for post-hospitalized congestive heart  
failure patients enrolled in FFS and HMO insurance plans affect comparable   
mortality rates? 
     To achieve the purpose of the study, secondary data were collected from an ongoing 
congestive heart failure monitor being implemented at the University of Tennessee 
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Medical Center, Knoxville (UTMCK).  Original case selection for the UTMCK study 
was based on a stratified random sample (by attending physician) of all patients 
discharged from UTMCK with a primary diagnosis of CHF.  For this study, data were 
collected from a total of 154 subjects.  The health outcome measurements for this study 
obtained from UTMCK's CHF monitor included the following: 
1.  Length of stay (days) 
     2.  Mortality 
     3.  Gender (male/female) 
     4.  Payor (FFS/HMO) 
     5.  Readmitted within 30 days of discharge with related condition 
    6.  Attending physician (cardiology, medicine, family practice, other) 
     7.  Treated with ACE inhibitor 
     8.  Follow-up with a health care provider within 2 weeks scheduled at 
             discharge 
     9.  Documentation of instruction (discharge instructions) 
      A.   Diet 
      B.  Weight 
      C.  Medications 
      D.  Activity level 
      E.  CHF teaching booklet 
In addition to the above health outcome measurements, the type of insurance was 
recorded with selection limited to patients enrolled in either a fee-for-service or health 
maintenance organization insurance plan.   
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     Data was analyzed using the following statistical tests.  To test the null hypothesis that 
average length of stay of FFS members is equal to the average length of stay of HMO 
members, an independent sample t-test was performed.  A Pearson's chi-square test of 
independence was used to determine whether or not the class of attending physician is 
dependent upon type of insurance.  An exposed odds ratio test was performed to compare 
the following outcome data: 
1. Mortality rates  
2. Readmission within 30 days with a related diagnosis 
3. Treated with ACE inhibitor 
4. Follow-up with health care provider scheduled at discharge 
5. Documentation of discharge teaching. 
Data was entered into a Microsoft Excel spreadsheet and statistically analyzed using 
SPSS version 11.0. 
 
 
FINDINGS 
     The data collected and statistical tests used to answer the three research questions 
produced the following findings: 
1. No statistically significant difference in the length of stay of HMO members 
compared to FFS members was found.  There was a shorter length of stay 
revealed in HMO members with an average of 4.95 days and 5.32 days for FFS 
members.   
2. Results revealed all six cases of mortality in FFS insurance plans, however an 
exposed odds ratio test did not indicate a statistically significant difference in 
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mortality rates due to sample size and distribution.  All six cases of mortality were 
found in patients ages 67 and up.  It was also discovered that an association 
between being age 67+ and enrolled in a FFS insurance plan was present.  
3. With a total of 154 cases, 22.6% of FFS members and 25.6% of HMO members 
were readmitted to the hospital within 30 days of discharge with a related 
diagnosis.  Although HMO members had a 3% higher readmission rate, an 
exposed odds ratio did not indicate a significant difference between the insurance 
plans. 
4. Payor source did not affect the probability of cases being attended by a specialist 
during their hospital stay.  A Pearsons chi square test of independence revealed 
no greater likelihood of FFS and HMO members being attended by cardiology, 
medicine, family practice, or other physician specialty. 
5. Payor source did not affect the likelihood of a patient being treated with an ACE 
inhibitor.  An exposed odds ratio did not reveal a significant difference in the 
number of patients treated with an ACE inhibitor between the insurance plans. 
6. No significant difference in the number of cases with scheduled health care 
provider follow-up within 30 days of discharge was found. 
7. No significant difference in cases with documentation of discharge teaching 
between the insurance plans was found. 
 
CONCLUSIONS 
     Based on the findings of this study the following conclusion was drawn: 
1.  Congestive heart failure patients discharged from the University of  
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Tennessee Medical Center, Knoxville enrolled in FFS or HMO insurance  
plans do not experience significant differences in quality of care as evidenced  
by the health outcomes collected for this study. 
 
RECOMMENDATIONS 
     Based on the data produced by this study, the following recommendations were made: 
1. The study should be replicated in other Knoxville, Tennessee hospitals to provide 
data generalizable to the geographic population. 
2. Further study into decreased length of stay and higher readmission rates among 
HMO insurance plans should be conducted. 
3. Investigation into documentation of teaching, follow-up scheduled at discharge, 
and the effect on readmission rates could provide data supporting the need for 
adequate teaching and follow up to decrease exacerbations and subsequent higher 
readmission rates. 
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APPENDIX A 
CONGESTIVE HEART FAILURE INSTRUMENT 
 
Indicator # % Comments 
 
Average Age (years)  
Average LOS (days) 
Median LOS (days) 
Mortality 
Gender: 
• Male 
• Female 
Payor: 
• Medicare 
• TN Care 
• Blue Cross 
• Other 
 
Readmitted within 30 days of this discharge with related 
condition 
 
Attending physician: 
• Cardiology 
• Medicine 
• Family Practice 
• Other 
 
Cardiology consulted if not attending 
 
Etiology of CHF documented 
 
Cases which had procedure to establish ejection fraction 
• MUGA 
• PET 
• ECHO 
• Cath 
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Indicator # % Comments 
 
Ejection fraction:  
• < 20 % 
• 20 - 30 % 
• 31 - 40 % 
• > 40 % 
 
No ejection fraction documented, but severe LV 
 dysfunction noted 
 
ACE Inhibitor 
• Cases receiving during hospitalization 
 
•  Cases which did not receive ACE inhibitor during 
hospitalization  
   # with absolute contraindication 
   # with relative contraindication 
   # with no documented contraindication 
 
• Discharged on ACE if not contraindicated 
 
Beta Blocker 
•  Cases receiving during hospitalization 
 
• Discharged on beta blocker if not contraindicated 
 
 
ASA 
• Cases receiving during hospitalization 
• Discharged on ASA if not contraindicated 
 
Coumadin 
• Cases receiving during hospitalization 
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Indicator # % Comments 
 
ARB  
• Cases receiving during hospitalization 
 
Spironolactone 
• Cases receiving during hospitalization 
 
Follow-up with a healthcare provider within 2 weeks 
 scheduled at discharge 
 
Home Care consulted 
 
Documentation of teaching (discharge instructions) 
• Diet 
• Weight 
• Meds 
• Activity Level 
• CHF Teaching Booklet 
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APPENDIX B 
DISTRIBUTION OF CASES BY AGE AND INSURANCE PLAN 
Appendix B:  Distribution of Cases by Age and Insurance Plan 
                Payor Age 
 FFS HMO 
Total 
    
19 Count  1 1 
 % within  100.0% 100.0% 
     
26 Count  1 1 
 % within  100.0% 100.0% 
 
        32 
 
Count 
 
1 
  
1 
 % within 100.0%  100.0% 
 
36 
 
Count 
  
1 
 
1 
 % within  100.0% 100.0% 
 
37 
 
Count 
 
1 
  
1 
 % within 100.0%  100.0% 
 
40 
 
Count 
 
1 
  
1 
 % within 100.0%  100.0% 
 
42 
 
Count 
 
1 
 
1 
 
2 
 % within 50.0% 50.0% 100.0% 
 
46 
 
Count 
  
1 
 
1 
 % within  100.0% 100.0% 
 
48 
 
Count 
  
4 
 
4 
 % within  100.0% 100.0% 
 
49 
 
Count 
  
2 
 
2 
 % within  100.0% 100.0% 
 
50 
 
Count 
 
1 
 
3 
 
4 
 % within 25.0% 75.0% 100.0% 
 
51 
 
Count 
 
2 
 
1 
 
3 
 % within 66.7% 33.3% 100.0% 
 
53 
 
Count 
 
2 
 
2 
 
4 
 % within 50.0% 50.0% 100.0% 
 
54 
 
Count 
 
3 
 
1 
 
4 
  % within 75.0% 25.0% 100.0% 
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Appendix B:  Distribution of Cases Continued 
Payor        Age 
 FFS HMO 
Total 
     
55 Count 1 2 3 
 % within 33.3% 66.7% 100.0% 
 
56 
 
Count 
  
1 
 
1 
 % within  100.0% 100.0% 
 
57 
 
Count 
  
4 
 
4 
 % within  100.0% 100.0% 
 
58 
 
Count 
 
1 
 
4 
 
5 
 % within 20.0% 80.0% 100.0% 
 
59 
 
Count 
 
1 
 
2 
 
3 
 % within 33.3% 66.7% 100.0% 
 
60 
 
Count 
  
1 
 
1 
 % within 100.0% 100.0% 100.0% 
 
61 
 
Count 
  
1 
 
1 
 % within  100.0% 100.0% 
 
62 
 
Count 
 
2 
 
1 
 
3 
 % within 66.7% 33.3% 100.0% 
 
63 
 
Count 
  
1 
 
1 
 % within  100.0% 100.0% 
 
64 
 
Count 
 
2 
  
2 
 % within 100.0%  100.0% 
 
65 
 
Count 
 
3 
  
3 
 % within 100.0%  100.0% 
 
66 
 
Count 
  
1 
 
1 
 % within  100.0% 100.0% 
 
67 
 
Count 
 
1 
  
1 
 % within 100.0%  100.0% 
 
68 
 
Count 
 
6 
  
6 
 % within 100.0%  100.0% 
 
69 
 
Count 
 
3 
  
3 
 % within 100.0%  100.0% 
 
70 
 
Count 
% within 
 
2 
100% 
  
2 
100% 
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Appendix B:  Distribution of Cases Continued 
Payor        Age 
 FFS HMO 
Total 
    
71 Count 
% within 
         3    
    100.0% 
3 
100.0% 
     
72 Count 6  6 
 % within 100.0%  100.0% 
 
73 
 
Count 
 
4 
  
4 
 % within 100.0%  100.0% 
 
74 
 
Count 
 
7 
 
2 
 
9 
 % within 77.8% 22.2% 100.0% 
     
75 Count 6  6 
 % within 100.0%  100.0% 
     
76 Count 1  1 
 % within 100.0%  100.0% 
     
77 Count 6  6 
 % within 100.0%  100.0% 
     
78 Count 2  2 
 % within 100.0%  100.0% 
     
79 Count 2  2 
 % within 100.0%  100.0% 
     
80 Count 6 1 7 
 % within 85.7% 14.3% 100.0% 
     
81 Count 5  5 
 % within 100.0%  100.0% 
     
        82 Count 6  6 
 % within 100.0%  100.0% 
     
83 Count 2  2 
 % within 100.0%  100.0% 
     
84 Count 5  5 
 % within 100.0%  100.0% 
     
85 Count 5  5 
 % within 100.0%  100.0% 
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Appendix B:  Distribution of Cases Continued 
                  Payor        Age 
  FFS       HMO 
Total 
    
86 Count 1  1 
 % within 100.0%  100.0% 
     
87 Count 2  2 
 % within 100.0%  100.0% 
     
89 Count 2  2 
 % within 100.0%  100.0% 
     
90 Count 3  3 
 % within 100.0%  100.0% 
     
92 Count 2  2 
 % within 100.0%  100.0% 
     
93 Count 1  1 
 % within 100.0%  100.0% 
     
        94 Count 1  1 
 % within 100.0%  100.0% 
     
95 Count 1  1 
 % within 100.0%  100.0% 
     
97 Count 1  1 
 % within 100.0%  100.0% 
     
98 Count 1  1 
 % within 100.0%  100.0% 
     
Total Count 115 39 154 
 % within 
 
74.7% 25.3% 100.0% 
     
     
 
 
 
 
 
 
 78
VITA 
 
     Pamela Driggers Silcox is originally from Vero Beach, Florida where she graduated 
with a high school diploma from Tabernacle Baptist Christian School in 1987.  In 1994 
she completed a Bachelor of Science in Nursing degree from East Tennessee State 
University where she was inducted into Sigma Theta Tau International Nurses Honor 
Society.  In 1999 she completed a Master of Public Health, Gerontology degree from the 
University of Tennessee, Knoxville.  While completing her Ph.D. in Human Ecology she 
worked as a Graduate Teaching Associate in the department of Health & Safety Sciences 
and received the Outstanding Teaching as a Graduate Student award in April of 2002.  
Her nursing experience includes extensive experience working with geriatric patients and 
especially congestive heart failure patients as a registered nurse at Baptist Hospital of 
East Tennessee and as a case manager for hospice and home health patients in the East 
Tennessee area.  Currently she is employed as part-time faculty at the University of 
Tennessee, Knoxville in the division of Distance Education and Independent Study 
coordinating Health 406K, Death, Dying, & Bereavement.  In addition, she works as a 
registered nurse consultant in the Medical Call Center at the University of Tennessee 
Medical Center.  She is a current member of the American Public Health Association. 
